Related Experiment Videos
New location for polytetrafluorethylene graft
1Hospital de Terrassa, Barcelona, Spain.
Insights
The Cimino-Brescia arteriovenous fistula, a key vascular access for haemodialysis since 1966, faces exhaustion due to frequent use and patient conditions. Research into new alternatives is crucial for ongoing treatment needs.
Area of Science:
- Vascular Surgery
- Nephrology
- Medical Devices
Background:
- The Cimino-Brescia arteriovenous fistula (FAVI) has been the primary vascular access for haemodialysis since its introduction in 1966.
- Regular use and patient comorbidities can lead to the exhaustion and failure of FAVIs.
Purpose of the Study:
- To highlight the long-standing importance of FAVIs in haemodialysis.
- To emphasize the need for continuous research into alternative vascular access methods due to FAVI limitations.
Main Methods:
- Historical review of vascular access for haemodialysis.
- Analysis of factors contributing to vascular access failure in chronic kidney disease patients.
Main Results:
- The FAVI remains the most utilized vascular access for haemodialysis.
- Vascular access can deteriorate over time owing to patient-related factors and treatment demands.
Conclusions:
- Despite its widespread use, the long-term efficacy of FAVIs is challenged by patient conditions and treatment intensity.
- Ongoing investigation into novel vascular access solutions is imperative to ensure sustained haemodialysis treatment for patients.
Abstract:
Cimino-Brescia performed in 1966 an internal by-pass between an artery and a peripheral vein resulting in an internal arteriovenous fistula (FAVI). Since then, it has been the most used and first chosen vascular access for haemodialysis. Due to the regular use of the access, as well as the patients' chronic condition and the associated pathologies, vascular access can become exhausted, necessitating continuous research and new alternatives to be resorted to.